Lowering cholesterol content in lipid rafts of cancer cells with cholesterol synthesis inhibitor statins has been shown to inhibit cell survival mediated by the AKT serine/threonine kinase and induce prostate cancer cell apoptosis [23]. Here, AKT1 is linked to cancer.